Rocket Pharmaceuticals
RCKT
RCKT
186 hedge funds and large institutions have $2.48B invested in Rocket Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 69 increasing their positions, 63 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $2.69B → $2.48B (-$201M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
186
Holding in Top 10
5
Calls
$20.7M
Puts
$3.6M
Top Buyers
| 1 | +$44.6M | |
| 2 | +$25.9M | |
| 3 | +$25.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$21.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$12.6M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$16.8M | |
| 3 | -$14.4M | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$7.59M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$4.92M |